Inhibiting HSCs Activation and Ameliorating Alcoholic Liver Fibrosis by Fucoidan Targeting the TLR4/NF‐κB Pathway
Journal of Food Science · 2025
DOI: 10.1111/1750-3841.70682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food Science, 2025. Verfasst von Guifa Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Qingdao University, Qingdao, PR China. Hauptthemen laut MEDLINE: Polysaccharides, Toll-Like Receptor 4, NF-kappa B, Hepatic Stellate Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Shandong Provincial Natural Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Alcoholic liver fibrosis (ALF) is a disease characterized by excessive deposition of liver fibrous tissue due to long‐term heavy alcohol consumption. Fucoidan is a naturally occurring sulfated polysaccharide extracted from brown algae. In terms of liver protection, fucoidan has shown an important role in the treatment of alcoholic liver injury. However, its therapeutic effects on ALF and the underlying mechanisms have not been fully elucidated. The objective of this study is to investigate the mechanism of fucoidan in ALF through network pharmacology, and to validate these findings using molecular docking technology and in vivo experiments. Molecular docking results showed that fucoidan had a strong binding affinity with toll‐like receptor 4 (TLR4), nuclear factor‐κB (NF‐κB), tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and interleukin‐6 (IL‐6), suggesting its potential to modulate the TLR4/NF‐κB pathway. In animal studies, the expression levels of proteins involved in the TLR4/NF‐κB signaling pathway were significantly decreased in mice treated with fucoidan. Fucoidan also inhibited the production of TNF‐α, IL‐1β, and IL‐6, while reducing the expression of α‐SMA, Collagen‐I, and Collagen‐III. These findings indicate that fucoidan could significantly alleviate alcohol + CCl 4 ‐induced ALF in mice by inhibiting the activation of hepatic stellate cells (HSCs).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Qingdao University, Qingdao, PR China.
- Department of Human Nutrition, College of Public Health, Qingdao University, Qingdao, PR China.
- The First Clinical College, Ningxia Medical University, Yinchuan, PR China.
- School of Biomedical Engineering, Sichuan University, Chengdu, PR China.
- Department of Adult and Geriatric Care, School of Nursing, Qingdao University, Qingdao, PR China.
ORCID-Profile: Guifa Wang
Förderung
- Shandong Provincial Natural Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, G., Zhang, N., Zhou, Y., Yan, J., Liu, Y., Liu, M., Xue, M., & Liang, H. (2025). Inhibiting HSCs Activation and Ameliorating Alcoholic Liver Fibrosis by Fucoidan Targeting the TLR4/NF‐κB Pathway. Journal of Food Science. https://doi.org/10.1111/1750-3841.70682
Vancouver
Wang G, Zhang N, Zhou Y, Yan J, Liu Y, Liu M, et al. Inhibiting HSCs Activation and Ameliorating Alcoholic Liver Fibrosis by Fucoidan Targeting the TLR4/NF‐κB Pathway. Journal of Food Science. 2025. doi:10.1111/1750-3841.70682
BibTeX
@article{Wang2025,
author = {Wang, Guifa and Zhang, Nan and Zhou, Yifan and Yan, Jiayi and Liu, Yuhan and Liu, Man and Xue, Meilan and Liang, Hui},
title = {Inhibiting HSCs Activation and Ameliorating Alcoholic Liver Fibrosis by Fucoidan Targeting the TLR4/NF‐κB Pathway},
journal = {Journal of Food Science},
year = {2025},
doi = {10.1111/1750-3841.70682}
}
EUVIMED